Recombinant Human GPIHBP1 (C-Fc)

Description

EnkiLife provides the Recombinant Human GPIHBP1 (C-Fc) protein,aslo know as glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein1,GPI anchored high density lipoprotein binding protein 1,GPI-Anchored HDL-Binding Protein 1,GPIHBP1,GPI-HBP1,GPI-HBP1LOC338328,HBP1,High density lipoprotein-binding protein 1,HYPL1D, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 is produced by our Mammalian expression system and the target gene encoding Thr22-Gly151 is expressed with a human IgG1 Fc tag at the C-terminus.Accession:Q8IV16. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:41.7 KDa. Background:Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) is a member of the Ly6 family of proteins, binds LPL in the subendothelial spaces and transports it to the capillary lumen. GPIHBP1 is an important regulator of triglyceride metabolism by increasing the efficiency of lydrolysis by LPL and uptake of fatty acids. GPIHBP1 was positively correlated with LPL, and GPIHBP1 is a better marker for body weight decrease than LPL.